Interestingly, 19 of the 33 overexpressed genes in the microarray non-relapsing signature and 13 out of the 16 genes in the RNA sequencing non-relapsing signature also belong to the “stromal-1 signature” (including FN1) associated with a better EFS and OS in diffuse large B-cell lymphomas (DLBCL) treated by CHOP or R-CHOP [39]. This evidence concerns the gene DDIT3 and diffuse large B-cell lymphoma.